Starpax Biopharma

Even though U.S. life expectancy has declined to 76.4 years, the shortest it's been in nearly two decades, there's hope it will begin to climb in the years to come. One doctor believes extending human life to 120 years is possible by 2030. And if that's not intriguing enough, he believes that...

Artificial intelligence's reach extends beyond making fantastical artwork or songs into the potential to save lives.  Detecting and treating cancer promptly is crucial to thwart its progression, but a significant challenge for healthcare professionals is identifying patients with high-risk tumors...

While many ninth graders are navigating the challenges of high school, a student from Virginia developed a cancer-killing soap that potentially encourages the body to fight off skin cancer. Heman Bekele, a ninth grader at W.T. Woodson High School, created the soap to help people live healthier...

Unlike the last few weeks, there were no nine-figure funding rounds this past week. But there were still plenty of head-turning deals that provided good vibes moving into the final months of the fourth quarter. Healthcare companies were the big winners, but up-and-coming players in many other...

Michael Gareau, Chairman of the Board, Founding President & CEO of Starpax Biopharma, was recently interviewed by Benzinga. Starpax is a biopharma and medtech company that has developed an innovative platform for treating cancer. The company has developed what it calls Magnetodrones, which...

The human body has healthy cells that reproduce to replace damaged or missing cells in the tissues. Cancer starts when one of those cells begins to have an abnormal reaction that causes it to reproduce perpetually. It takes approximately one billion of these cancer cells to end up with a ¾-...

Funding has been hard to come by in 2023, but some companies have had great success breaking down the walls and securing the cash they need to grow. Last week, companies in artificial intelligence (AI), biotech and space raised more than $2 billion combined. Could this be a sign of bigger things to...

Michael Gareau, Chairman of the Board, Founding President & CEO of Starpax Biopharma Inc., was recently interviewed by Benzinga. Starpax is a biopharma and medtech company that has developed a revolutionary platform for treating cancer. The company has developed what it calls Magnetodrones...

A significant breakthrough in cancer treatment recently came from biomedical engineering professor Yosi Shamay and a group of researchers at Technion – Israel Institute of Technology. The team's approach, which it calls meta-synergy, uses artificial intelligence (AI) technology to run simulations...

The Bill & Melinda Gates Foundation is known for spending big money to fight infectious diseases in developing countries. While that's a noble cause, the foundation isn't afraid to invest elsewhere.  Earlier this year, it invested $5 million in Smart Immune to develop a technique to turn...

Starpax Biopharma is preparing to start clinical trials this year with its patented Starpax cancer treatment platform across six unmet needs, including pancreatic, breast, colorectal, head & neck, uterus and prostate cancer. Solid cancers like the ones Starpax will focus on in the upcoming...